Drug intelligence / Profile preview

calcitriol + calcium

Development stage
Approved
Lead developer
National Institute of Child Health and Human Development
Modality
Small Molecules
Administration
Oral
01

Overview

Calcitriol + calcium is a combination therapy utilized as the conventional standard of care for the management of hypoparathyroidism, particularly in clinical research conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Calcitriol, the active form of vitamin D3 (1,25-dihydroxyvitamin D3), acts as an agonist at the vitamin D receptor (VDR) to enhance intestinal absorption of calcium and phosphorus. Supplemental calcium (often as calcium carbonate) provides the necessary elemental calcium to maintain serum levels in the absence of adequate parathyroid hormone (PTH). This regimen is used to prevent hypocalcemia and its associated symptoms, although it does not address the full physiological spectrum of PTH deficiency, such as impaired renal calcium reabsorption and phosphate excretion.

Other names
Calcitriol and CalciumConventional therapy for hypoparathyroidismCalcitriol & Calcium
02

Targets

CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on calcitriol + calcium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcitriol + calcium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call